Progess on research of herpes simplex virus type 1 mutants for cancer therapy

Long, Y.; Mi, Y.; Li, Y.

Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 25(6): 1446-1449

2008


ISSN/ISBN: 1001-5515
PMID: 19166228
Document Number: 619345
For a long time past viruses have been recognized as being tumoricidal. At present, researchers are still pursuing studies and constructing more suitable oncolytic viruses for treating different malignant tumors. Herpes simplex virus type 1 (HSV-1) has been known as the most potential oncolytic virus among all the viruses. In this overview, we summarize the current situation of oncolytic viruses, the biology of HSV-1, its construction and application of its recombinant, and we debate on the feasibility and prospect of HSV-1 mutants labeled with radionuclides for cancer therapy.

Document emailed within 1 workday
Secure & encrypted payments